Write your message
Volume 4, Issue 1 (Winter 2019)                   jogcr 2019, 4(1): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Behnam Far F, Eghbali K, Mousavi Seresht L. Assessment of Response Rate in Patients with Gestational Trophoblastic Neoplasia: A Case Study of Healthcare Centers in Isfahan from 2011 to 2016. jogcr. 2019; 4 (1)
URL: http://jogcr.com/article-1-220-en.html
1- Department of Obstetrics & Gynecology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
2- School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , kh.eghbali72@gmail.com
Abstract:   (59 Views)
Background: Gestational trophoblastic neoplastic (GTN) as the one of curable malignancy all around the world has higher incidence rate in developing country, so study on its behavior, risk factor, and treatment failure reason is encouraging in such countries
Methods: This study was a descriptive, cross-sectional study which tries to examine the GTN cases medical record in referral university hospitals in Isfahan from 2011 to 2016 to examine the risk factor and the factor that affecting treatment response rate. The patients were studied in two divided group based on the FIGO scoring system.
Results: 70 GTN patients were identified over these 5 years. 59 patients were in the low-risk group and 11 patients were in the high-risk group. 100% of the patients in the low-risk group and 90.1% of the patients in the high-risk group responded to the first and second line treatment. In the follow-up one case of recurrence within the low risk patient and one case of mortality from the high-risk patients was reported. In the high-risk metastatic group, there was 1 case of unusual metastasis site at the kidney and the commonest site of distant metastasis was lung.
Conclusion: Response rate in the low-risk GTN patients was excellent (100%) and it was more than 90% in the high-risk GTN patients. Therefore, if GTN patients are treated in reference centers, the response rate will be favorable. Patients with brain metastases have good chances of recovery if treated timely.
  |   |   Full-Text (HTML)  (3 Views)  
Systematic Review: Original Research | Subject: Gynecology Oncology
Received: 2019/09/2 | Accepted: 2019/10/13

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.